http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Northern Tool + Equipment Gives Back with Donation to Several Schools and Feed My Starving Children
-
The International Myeloma Foundation Mourns the Loss of Accomplished Attorney and Longtime Board Member Benson Klein
-
Hyundai Tucson Hybrid Named One of the 2025 Best Cars for Car Seats by Cars.com
-
Conduent Expands Finance and Procurement Capabilities with Fairmarkit's AI-Powered Technologies including GenAI
-
Kilgore EDC Receives Top Business Retention and Expansion Honor
-
American Resources regains compliance with NASDAQ minimum bid price rule
-
Slingshot Aerospace Launches TALOS: AI Agent for Mission-Ready Space Operations and Strategy
-
American Resources Corporation Reaffirms Compliance with Nasdaq Listing Standards
-
MDA SPACE selected to lead Canada's lunar utility vehicle study
-
TEAM LED BY MDA SPACE SELECTED FOR CANADA'S LUNAR UTILITY VEHICLE STUDY
-
New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
-
Avant Technologies revises clinical trial protocol after FDA meeting
-
Hissho Sushi and Mike's Hot Honey Launch First-Ever Hot Honey Maple Smoked Salmon Roll: A Bold Fusion of Heat and Sweet
-
AbbVie seeks FDA approval for VENCLEXTA-acalabrutinib combination
-
Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results
-
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
-
SusGlobal(R) Announces Additional Sales of Carbon Credits and VERRs Generated from Its Belleville Composting Offset Project
-
AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
-
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
-
Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback
-
Alchemy Pay Collaborates with Ondo Finance to Support Fiat On-Ramp for USDY, a Tokenized US Treasury-Backed Asset
-
Premier Financial Credit Union Selects Mahalo Banking to Power Digital Banking Scalability
-
PMN Hits $1M in Pre-Sales -- A Compliant Way to Accumulate Bitcoin Over Time
-
Brixton Metals Drills 16m of 3.4 g/t Gold, 96 g/t Silver, 0.59% Copper, 0.12% Antimony at the Glenfiddich Zone, Camp Creek Corridor
-
Beyond Lithium Announces Amended LIFE Offering and Debt Settlement Agreement
-
Trevi Therapeutics to Participate in Upcoming August Conferences
-
Bausch Health to acquire DURECT for $63 million upfront
-
Bausch Health to acquire DURECT for $63 million upfront
-
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
-
ARway Corp Reports +277% Revenue Growth and 87% Reduction in Net Loss in Audited Financial Results
-
Premier American Uranium Reports Positive Drill Results from the Cyclone ISR Project, Wyoming
-
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
-
Hughes Earns AS9100 Certification, Reinforcing Commitment to Aerospace, Aviation, and Defense Excellence
-
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025
-
TVA Reports Third Quarter Fiscal Year 2025 Financial Results
-
Fulcrum Therapeutics reports Q2 results, pociredir trial data
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
-
Fulcrum reports positive Phase 1b trial results for sickle cell drug
-
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
-
Order Up! Take a Trip to the Pizzeria with Kraft Mac & Cheese’s New Limited-Edition Pizza Flavor
-
Finland tops annual global mining survey rankings, Ethiopia ranks last
-
DealMakerInsider.com Publishes a New White Paper for M&A Advisors on Reframing Sell-Side Qualification in Tech
-
Star Copper Gains Confidence for Robust Porphyry System at Depth Across Star Deposit in Golden Triangle Region
-
$1 (1DollarSol) Memecoin Relaunches as Community-Led Movement Against Inflation and Dollar Erosion
-
AudioCodes Reports Second Quarter 2025 Results and Declares Semi-Annual Dividend of 20 cent per share
-
Predictino Launches Public PREDINO Presale to Bring AI Forecasting to Crypto Traders
-
Kinvard Bio Secures Follow-on CARB-X Funding to Accelerate Development of Next-Generation Antibiotics
-
Bitget Launchpool Features GAIA with over 4.7M Tokens in Rewards
-
ARO Network Raises $2.1M to Scale the Decentralized Edge Cloud for AI and Content Delivery
-
Jask Auto Parts Inc Announces Revolution in Used Auto Parts Market with Customer First Approach
